NMPA Approval

Immunoglobulin Ribonucleic Acid of Anti Hepatitis B for Injection

Approval Number

国药准字H33022305

Company浙江杭康药业有限公司

Registration Date

January 19, 2021

Previous Approval Numbers

国药准字H33022305

Drug Information

Generic Name

注射用抗乙肝免疫核糖核酸

Dosage Form

注射剂

Strength

2mg

Drug Type

化学药品

Registration Date

January 19, 2021

Company Information

Applicant Company

Company Name浙江杭康药业有限公司

Company Address

浙江省杭州市杭州经济技术开发区12号大街266号

Manufacturing Company

Company Name浙江杭康药业有限公司

Company Address

杭州市杭州经济技术开发区12号大街266号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用抗乙肝免疫核糖核酸 - NMPA 批准文号 | MedPath